David M Peng1, Devin A Koehl2, Ryan S Cantor2, Kristen N McMillan3, Aliessa P Barnes4, Patrick I McConnell5, Jessica Jordan6, Nicholas D Andersen7, James D St Louis4, Katsuhide Maeda8, James K Kirklin2, Steven J Kindel9. 1. Department of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: davepeng@med.umich.edu. 2. Kirklin Institute for Research in Surgical Outcomes, University of Alabama at Birmingham, Birmingham, Alabama, USA. 3. Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA. 4. Department of Pediatrics, Division of Pediatric Cardiology, University of Missouri-Kansas City, Kansas City, Missouri, USA. 5. Department of Cardiothoracic Surgery, The Ohio State University, Columbus, Ohio, USA. 6. Department of Pediatrics, Division of Pediatric Cardiology, University of Michigan, Ann Arbor, Michigan, USA. 7. Department of Cardiac Surgery, Harvard University, Boston, Massachusetts, USA. 8. Department of Cardiothoracic Surgery, Stanford University, Palo Alto, California, USA. 9. Department of Pediatrics, Division of Pediatric Cardiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Abstract
BACKGROUND: The reported ventricular assist device (VAD) experience in the pediatric congenital heart disease (CHD) population is limited. We sought to describe contemporary use and outcomes of VADs in children with CHD and compare these outcomes to those of non-CHD children. METHODS: Patients enrolled in the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) between September 19, 2012 through June 30, 2017 were included. CHD was classified as biventricular vs single ventricle (Stages 1, 2, or 3). Outcomes were compared between groups and multivariable analysis was used to identify factors associated with mortality on the device. RESULTS: Among the 471 patients enrolled, 108 (24%) had CHD (45 biventricular and 63 single ventricle). CHD patients were younger (5.7 ± 5.7 years vs 9.8 ± 6.5 years; p < 0.0001) and smaller (0.8 ± 0.5 m2 vs 1.2 ± 0.7 m2; p < 0.0001) compared with non-CHD patients. CHD patients were more likely to receive a paracorporeal continuous-flow VAD (36.1% vs 12.9%; p < 0.0001) and less likely to receive an implantable continuous-flow VAD (27.8% vs 55.0%; p < 0.0001) compared with non-CHD patients. After 6 months on a VAD, CHD patients had higher mortality (36.4% vs 12.1%) and a lower transplantation rate (29.1% vs 59.9%) than non-CHD patients (p < 0.0001). In the multivariable analysis, CHD was the factor most strongly associated with mortality on VAD (hazard ratio [HR] = 2.9; p < 0.0001), whereas the factors implantable continuous-flow device and high-volume center were protective (HR = 0.3, p < 0.0001, and HR = 0.6, respectively; p = 0.02). CONCLUSIONS: VAD use in children with CHD is associated with increased mortality and decreased transplant rates compared to children without CHD. For the subgroup of children with CHD who received implantable continuous-flow VADs, survival rates were higher and comparable to those of children without CHD. Increased experience correlated with better survival in pediatric VADs.
BACKGROUND: The reported ventricular assist device (VAD) experience in the pediatric congenital heart disease (CHD) population is limited. We sought to describe contemporary use and outcomes of VADs in children with CHD and compare these outcomes to those of non-CHDchildren. METHODS:Patients enrolled in the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) between September 19, 2012 through June 30, 2017 were included. CHD was classified as biventricular vs single ventricle (Stages 1, 2, or 3). Outcomes were compared between groups and multivariable analysis was used to identify factors associated with mortality on the device. RESULTS: Among the 471 patients enrolled, 108 (24%) had CHD (45 biventricular and 63 single ventricle). CHD patients were younger (5.7 ± 5.7 years vs 9.8 ± 6.5 years; p < 0.0001) and smaller (0.8 ± 0.5 m2 vs 1.2 ± 0.7 m2; p < 0.0001) compared with non-CHDpatients. CHD patients were more likely to receive a paracorporeal continuous-flow VAD (36.1% vs 12.9%; p < 0.0001) and less likely to receive an implantable continuous-flow VAD (27.8% vs 55.0%; p < 0.0001) compared with non-CHDpatients. After 6 months on a VAD, CHD patients had higher mortality (36.4% vs 12.1%) and a lower transplantation rate (29.1% vs 59.9%) than non-CHDpatients (p < 0.0001). In the multivariable analysis, CHD was the factor most strongly associated with mortality on VAD (hazard ratio [HR] = 2.9; p < 0.0001), whereas the factors implantable continuous-flow device and high-volume center were protective (HR = 0.3, p < 0.0001, and HR = 0.6, respectively; p = 0.02). CONCLUSIONS: VAD use in children with CHD is associated with increased mortality and decreased transplant rates compared to children without CHD. For the subgroup of children with CHD who received implantable continuous-flow VADs, survival rates were higher and comparable to those of children without CHD. Increased experience correlated with better survival in pediatric VADs.
Authors: Heather J Ross; Yuk Law; Wendy M Book; Craig S Broberg; Luke Burchill; Frank Cecchin; Jonathan M Chen; Diego Delgado; Konstantinos Dimopoulos; Melanie D Everitt; Michael Gatzoulis; Louise Harris; Daphne T Hsu; Jeffrey T Kuvin; Cindy M Martin; Anne M Murphy; Gautam Singh; Thomas L Spray; Karen K Stout Journal: Circulation Date: 2016-01-21 Impact factor: 29.690
Authors: Brody Wehman; Kristen A Stafford; Gregory J Bittle; Zachary N Kon; Charles F Evans; Keshava Rajagopal; Nicholas Pietris; Sunjay Kaushal; Bartley P Griffith Journal: Ann Thorac Surg Date: 2016-02-22 Impact factor: 4.330
Authors: David L S Morales; Farhan Zafar; Joseph W Rossano; Jorge D Salazar; John L Jefferies; Daniel E Graves; Jeffrey S Heinle; Charles D Fraser Journal: Ann Thorac Surg Date: 2010-10 Impact factor: 4.330
Authors: Farhan Zafar; Chesney Castleberry; Muhammad S Khan; Vivek Mehta; Roosevelt Bryant; Angela Lorts; Ivan Wilmot; John L Jefferies; Clifford Chin; David L S Morales Journal: J Heart Lung Transplant Date: 2014-10-14 Impact factor: 10.247
Authors: Joseph W Rossano; Jeffrey J Kim; Jamie A Decker; Jack F Price; Farhan Zafar; Daniel E Graves; David L S Morales; Jeffrey S Heinle; Biykem Bozkurt; Jeffrey A Towbin; Susan W Denfield; William J Dreyer; John L Jefferies Journal: J Card Fail Date: 2012-04-10 Impact factor: 5.712
Authors: Christopher S D Almond; Ravi R Thiagarajan; Gary E Piercey; Kimberlee Gauvreau; Elizabeth D Blume; Heather J Bastardi; Francis Fynn-Thompson; T P Singh Journal: Circulation Date: 2009-01-26 Impact factor: 29.690
Authors: David N Rosenthal; Christopher S Almond; Robert D Jaquiss; Christine E Peyton; Scott R Auerbach; David R Morales; Deirdre J Epstein; Ryan S Cantor; Robert L Kormos; David C Naftel; Ryan J Butts; Nancy S Ghanayem; James K Kirklin; Elizabeth D Blume Journal: J Heart Lung Transplant Date: 2016-03-17 Impact factor: 10.247
Authors: Samuel Weinstein; Ricardo Bello; Christian Pizarro; Francis Fynn-Thompson; James Kirklin; Kristine Guleserian; Ronald Woods; Christine Tjossem; Robert Kroslowitz; Patricia Friedmann; Robert Jaquiss Journal: J Thorac Cardiovasc Surg Date: 2013-11-28 Impact factor: 5.209
Authors: Elizabeth D Blume; David N Rosenthal; Joseph W Rossano; J Timothy Baldwin; Pirooz Eghtesady; David L S Morales; Ryan S Cantor; Jennifer Conway; Angela Lorts; Christopher S Almond; David C Naftel; James K Kirklin Journal: J Heart Lung Transplant Date: 2016-02-10 Impact factor: 10.247
Authors: Silvio H Litovsky; Jeremy B Foote; Abhijit Jagdale; Gregory Walcott; Hayato Iwase; Mohamed H Bikhet; Takayuki Yamamoto; Christophe Hansen-Estruch; Mohamed B Ezzelarab; David Ayares; Waldemar F Carlo; Leslie A Rhodes; Jack H Crawford; Santiago Borasino; Robert J Dabal; Luz A Padilla; Hidetaka Hara; David K C Cooper; David C Cleveland Journal: Ann Transplant Date: 2022-07-05 Impact factor: 1.479
Authors: Matteo Ponzoni; Anna C Frigo; Biagio Castaldi; Alessia Cerutti; Giovanni Di Salvo; Vladimiro L Vida; Massimo A Padalino Journal: Artif Organs Date: 2021-09-12 Impact factor: 2.663
Authors: Joshua M Friedland-Little; Anna Joong; Svetlana B Shugh; Matthew J O'Connor; Neha Bansal; Ryan R Davies; Michelle S Ploutz Journal: Pediatr Cardiol Date: 2022-03-24 Impact factor: 1.838